Podbit · The Peter Attia Drive
Among real women with breast cancer, annual screeners had an 11% interval cancer rate versus 38% for biennial screeners, and a 76% versus 56% rate of stage 1 diagnosis. These are not marginal differences — they are survival-relevant.
Where this was said
At 33:27 · chapter starts 30:15
The debate between annual and biennial mammography is one of the most consequential and most misunderstood in preventive medicine. Peter Attia starts by acknowledging an important evidentiary gap: no randomised controlled trial has ever directly compared the two intervals with mortality as its primary endpoint. Every recommendation rests on modelling studies and observational data. The most important models come from CISNet, commissioned three times by the USPSTF. Counterintuitively, the same CISNet data that the USPSTF used to justify biennial screening have been interpreted by other major cancer and radiology groups as supporting annual screening. The resolution lies in understanding which question is being asked. The USPSTF asked: what gives the best population-level trade-off between benefit, cost, and false positives? The answer to that question may indeed be biennial. But if the question is what gives an individual woman the best chance of not dying from breast cancer, CISNet's 2024 comprehensive analysis — which incorporated both 2D digital mammography and DBT — answers clearly: annual screening of women aged 40–79 produced a 42% mortality reduction versus 30% for biennial, corresponding to 230 versus 165 life-years gained per 1,000 women [1] — Peter Attia "Annual vs biennial: 42% vs 30% mortality reduction: CISNet's 2024 analysis found annual screening reduces breast cancer mortality by 42% ve…" 32:15 . Importantly, while annual screening produces more cumulative false positives, the per-exam false positive rate is actually lower for annual screeners, likely because radiologists have a more recent baseline image for comparison. Observational data reinforce the models: annual screeners had an interval cancer rate of 11% versus 38% for biennial screeners, and 76% versus 56% stage 1 diagnosis rates [2] — Peter Attia "Interval cancers: 11% annual vs 38% biennial: Among women with breast cancer aged 40–84, annual screeners had far fewer interval cancers (1…" 33:30 . Attia's verdict is unambiguous: 'If your goal is to maximize your chances of avoiding death from breast cancer as an individual, annual mammography is the better strategy.'
CISNet's own 2024 models show annual screening reduces breast cancer mortality by 42% versus 30% for biennial — 230 life-years gained per 1,000 women versus 165. The biennial recommendation was built for population budgets, not individual survival.
CISNet's 2024 analysis found annual screening reduces breast cancer mortality by 42% versus 30% for biennial — translating to 230 vs 165 life-years gained per 1,000 women.
Among women with breast cancer aged 40–84, annual screeners had far fewer interval cancers (11%) versus biennial screeners (38%), and were more likely to have stage 1 diagnoses.
AI nailed Andrew Huberman's vertigo-vs-low-blood-pressure diagnosis because that pattern has been reported millions of times. But every patient's liver is different and data on liver surgeries is scarce worldwide — making solo robot surgery dangerous. The rule is simple: data abundance means AI can help; data scarcity means keep the human in the loop.
Fei-Fei Li's father had liver surgery performed by a da Vinci robot guided by a surgeon. The result: 10 times less blood loss than a typical procedure. This isn't replacement — it's the gold standard of human-machine collaboration, where the human's judgment and the robot's precision combine.
US drug overdose deaths fell from 110,000 to roughly 70,000 — the biggest CDC-recorded single-year drop ever. Men's rates fell 27% in one year, and the steepest decline of all was among 15–24-year-olds, down 37%. The crisis narrative around young men needs to make room for signs of genuine progress.
Kessler thought his grief expertise would protect him. It didn't. When his son David died unexpectedly, he found himself on the floor — and eventually realized that acceptance alone wasn't enough. That unmet need became the sixth stage: finding meaning.
Grief isn't just death — it's any unwanted change. Kessler lectured at Coca-Cola and General Mills not because they had lots of funerals, but because change management is grief management. People who grieve well live well.
Witnessing someone's grief isn't just emotional support — it's an essential act of healing. Kessler argues grief is a severance and connection heals it. But real witnessing has two steps: seeing the pain AND affirming the person's capacity to recover.
Avoiding grief isn't free — it's exhausting. Kessler's beach ball metaphor nails it: pushing a small balloon down is easy, but holding a massive beach ball underwater takes constant, draining energy. Unattended feelings don't disappear; they just consume you.
Most people try to control their environment to avoid triggers. Kessler flips this entirely: triggers aren't problems to manage around — they're a detailed map to your pain and your healing. Every trigger points directly to what needs attention.
Running from pain doesn't leave it behind — it accelerates the chase. Whatever we run from pursues us, and whatever we face transforms us. Both Kessler and Lewis Howes testify to knowing both roads firsthand.
We use essential and analytics cookies to run Vuci. To understand how the site is used: Privacy Policy.
Install Vuci on your phone
Add it to your home screen for a faster, app-like experience.
Install Vuci on your phone
Tap the Share button, then “Add to Home Screen”.
A new version is available
Reload to get the latest Vuci.